Lipid profile and treatment results in adults aged 25–64 in Czechia: a cross-sectional study
Abstract
Cardiovascular diseases (CVDs) remain the leading cause of death in Czechia. This is caused by the persistently high prevalence of several CVD risk factors, including dyslipidemia. Our goal was to establish the success rate of meeting the study-defined lipid control. We used data from the Czech cross-sectional study EHES 2019 (European Health Examination Survey), which is an epidemiological study with a stratified random sampling design. All parameters were assessed according to standardized criteria. The data were analyzed via descriptive statistics and group comparisons. A total of 1057 participants (426 men and 631 women) aged 25–64 years were included in the study. The most common risk factor was dyslipidemia, accounting for 71.7% of the studied population. The shares of participants with risk values of the lipid spectrum indicator were distributed as follows: 54.3% for total cholesterol; 52.3% for LDL-C; 8.7% for HDL-C; 41.1% for non-HDL-C; and 27.6% for TAG. The percentage of subjects with dyslipidemia who were aware of this disorder was 33.4%, while that of respondents with knowledge of dyslipidemia treated with lipid-lowering drugs was 27.7%. The measured lipid levels met the study-defined normal values in only 23.7% of the treated participants. The study revealed not only a low awareness among patients of their conditions but also a low efficacy in achieving lipid goals.
Related
- Cardiovascular risk profile and treatment patterns in patients with type 2 diabetes in specialized cardiology outpatient care in Colombia : A retrospective cross-sectional study
- Thyroid Function and Glycemic Profile in Adults with Abnormal Thyroid Function Tests and a Euthyroid Comparison Group: A Cross-Sectional Study from Jazan, Saudi Arabia
- Stressful and potentially traumatic life events and satisfaction with life among Norwegian adults: cross-sectional results from the seventh survey of the Tromsø study
- Clinicopathological Profile, Treatment Patterns and Documented Clinical Outcomes of Women with Breast Cancer at Shendi Hospital, Sudan: A Retrospective, Single-Center, Hospital-Based Cross-Sectional Study.
- Normative profile of retinal nerve fiber layer thickness using spectral domain optical coherence tomography in healthy Omani adults with emmetropic eyes: a cross-sectional study
BibTeX
@article{michalec2026lipid,
title = {{Lipid profile and treatment results in adults aged 25–64 in Czechia: a cross-sectional study}},
author = {Juraj Michalec and Michala Lustigová and Kristýna Žejglicová and Jana Malinovská and Pavlína Krollová and Kanupriya Goyal and Eldin Fahmy and Martin Wasserbauer and Marika Koželuhová and Natália Michalcová and Denisa Janíčková Žďárská and Pavlína Piťhová and Jan Brož},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-77844-4},
url = {https://www.nature.com/articles/s41598-026-77844-4},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Lipid profile and treatment results in adults aged 25–64 in Czechia: a cross-sectional study
AU - Juraj Michalec
AU - Michala Lustigová
AU - Kristýna Žejglicová
AU - Jana Malinovská
AU - Pavlína Krollová
AU - Kanupriya Goyal
AU - Eldin Fahmy
AU - Martin Wasserbauer
AU - Marika Koželuhová
AU - Natália Michalcová
AU - Denisa Janíčková Žďárská
AU - Pavlína Piťhová
AU - Jan Brož
PY - 2026
DA - 2026/10/27
JO - Scientific Reports
DO - 10.1038/s41598-026-77844-4
UR - https://www.nature.com/articles/s41598-026-77844-4
AB - Cardiovascular diseases (CVDs) remain the leading cause of death in Czechia. This is caused by the persistently high prevalence of several CVD risk factors, including dyslipidemia. Our goal was to establish the success rate of meeting the study-defined lipid control. We used data from the Czech cross-sectional study EHES 2019 (European Health Examination Survey), which is an epidemiological study with a stratified random sampling design. All parameters were assessed according to standardized criteria. The data were analyzed via descriptive statistics and group comparisons. A total of 1057 participants (426 men and 631 women) aged 25–64 years were included in the study. The most common risk factor was dyslipidemia, accounting for 71.7% of the studied population. The shares of participants with risk values of the lipid spectrum indicator were distributed as follows: 54.3% for total cholesterol; 52.3% for LDL-C; 8.7% for HDL-C; 41.1% for non-HDL-C; and 27.6% for TAG. The percentage of subjects with dyslipidemia who were aware of this disorder was 33.4%, while that of respondents with knowledge of dyslipidemia treated with lipid-lowering drugs was 27.7%. The measured lipid levels met the study-defined normal values in only 23.7% of the treated participants. The study revealed not only a low awareness among patients of their conditions but also a low efficacy in achieving lipid goals.
SN - 2045-2322
ER -